VEGFR2/CD309 anticorps (AA 20-125)
Aperçu rapide pour VEGFR2/CD309 anticorps (AA 20-125) (ABIN6254233)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 20-125
-
Specificité
- This antibody reacts with a 180 kDa protein and detects endogenous levels of total VEGFR2 protein.
-
Attributs du produit
- Kinase insert receptor (a type III receptor tyrosine kinase)
-
Purification
- epitope affinity purified
-
Immunogène
- Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Conseil sur la manipulation
- The antibody solution should be gently mixed before use.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- For continuous use, store at 2-8 deg,C for one-two days. For extended storage, store in -20 deg,C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- VEGFR2
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-